patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: excerpted also "Except in their capacity as shareholders

excerpted also "Except in their capacity as shareholders

posted on May 11, 2008 06:50AM
(which interest does not differ from that of the other common shareholders)none of our officers, directors, or any of their respective affiliates has any interest in increasing the amount of our athhorized shares of common stock."
Share
New Message
Please login to post a reply